Toggle light / dark theme

Summary: A recently announced parabiosis trial in humans – the practice of transfusing young blood to old – may have profound implications for treating the chronic diseases of old age, including metabolic changes, frailty, Alzheimer’s, Parkinson’s, and other forms of dementia. However, some geroscientists say that variations of the procedure could cause severe side effects. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman. ]

The idea that youthful blood might rejuvenate our aging bodies has lingered in the popular imagination for centuries, fueled by recent experiments in which these transfusions revitalized aging mice.

Last week, Bill Faloon of the Life Extension Foundation (LEF) in partnership with the Young Blood Institute (YBI), announced a bold new human trial of the rejuvenating effects of the young blood / old blood swap, saying.

Read more

Five technologies in development – including senolytic drugs, rapamycin, stem cell therapy, NAD supplementation and gene therapy – could dramatically slow down aging in the next few years. This report updates the latest developments in these promising and potentially lifespan-extending treatments. [This article first appeared on the website LongevityFacts. Author: Brady Hartman. ]

The longevity science field has made enormous progress in recent years, and human trials of anti-aging compounds have already started, with more to begin soon. The lifespan-extension research field is gaining the attention of mainstream medicine.

The specialists who populate the field, called geroscientists, are developing several technologies that might benefit people who are alive today and aim to bring them to the clinic. These lifespan-extending technologies include stem cell therapy, rapamycin, gene therapy, senolytic drugs, and NAD supplementation.

Read more

Image: Stratolaunch Billionaires are taking to space the way wistful young men take to the sea in 19th Century novels. Last week, Elon Musk launched his Tesla Roadster at the astroid belt using the world’s most powerful rocket currently in operation. Not to be outdone, Microsoft’s co-founder Paul Allen also has a big plan (and a big plane) for going to space. In December of last year, the Stratolaunch performed its first taxi at the Mojave Air & Space Port in Mojave, CA. While that doesn’t seem terribly exciting, it’s the first step to getting the Stratolaunch, the world’s largest plane eve…

Read more

MIT 6.S099: Artificial General Intelligence class takes an engineering approach to exploring possible research paths toward building human-level intelligence. The lectures introduce our current understanding of computational intelligence and ways in which strong AI could possibly be achieved, with insights from deep learning, reinforcement learning, computational neuroscience, robotics, cognitive modeling, psychology, and more.

Lex Fridman

Ray Kurzweil is one of the world’s leading inventors, thinkers, and futurists, with a thirty-year track record of accurate predictions. Called “the restless genius” by The Wall Street Journaland “the ultimate thinking machine” by Forbes magazine, Kurzweil was selected as one of the top entrepreneurs by Inc. magazine, which described him as the “rightful heir to Thomas Edison.” PBS selected him as one of the “sixteen revolutionaries who made America.”

Read more

To achieve this, the government is hoping to find more scientists like Koul, who sees his role as an “opportunity to address bigger social as well as scientific challenges”.

This is a tall order, and there’s an elephant in the room. Government funding for Indian research and development has stagnated at around 0.85% of gross domestic product for more than a decade, compared with at least 3% invested by technologically advanced nations such as Denmark, Japan and Sweden.


A push to reverse its brain drain is providing the expertise to tackle its domestic problems.

Read more